权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Mechanisms and Consequences of Calcification in Aortic Valvular Stenosis

主动脉瓣狭窄钙化的机制和后果

基本信息

批准号：
8477961
负责人：
DONALD D HEISTAD
金额：
$ 40.34万
依托单位：
UNIVERSITY OF IOWA
依托单位国家：
美国
项目类别：
财政年份：
资助国家：
美国
起止时间：
至
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/8477961
关键词：
AGTR2 gene Address Adipocytes Affect Agonist Angiotensin II Type 1 Receptor Blockers Angiotensin-Converting Enzyme Inhibitors Angiotensins Anti-Inflammatory Agents Antioxidants Aortic Valve Stenosis Apolipoproteins B Cardiac Surgery procedures Cardiovascular system Clinical Clinical Research Clinical Treatment Data Development Disease Dominant-Negative Mutation Elderly Endothelium Experimental Models Functional disorder Funding Gene Expression Genes Goals Hepatic Inflammation Instruction Intervention Lead Ligands Losartan Measures Medical Molecular Mus NF-kappa B Osteoblasts Oxidative Stress Pathway interactions Peptidyl-Dipeptidase A Pioglitazone Play Predisposition Proteins Publishing Reading Receptor, Angiotensin, Type 1 Renin Renin-Angiotensin System Research Personnel Role Sclerosis Severities Signal Transduction Staging Stem cells Stenosis Stress Superoxides System Testing Therapeutic Tumor necrosis factor receptor 11b advanced disease aortic valve calcification hypercholesterolemia novel therapeutic intervention osteogenic prevent programs receptor

项目摘要

Studies during the current period of funding have focused on cardiovascular effects of oxidative stress. The investigators observed oxidative stress in the aortic valve of "Reversa" (ldl"'7apoB^¿¿'^¿¿/Mttp'""/Mx1- Cre**) mice, and found that 1/3 ofthe mice develop moderately severe calcific aortic valvular stenosis (CAVS). The investigators now propose to test the hypotheses that 1) local and humoral mechanisms associated with oxidative stress and infiammation contribute to development of CAVS, and 2) mechanisms that reduce oxidative stress and infiammation inhibit development and progression of CAVS. A medical intervention to slow the progression of CAVS would be of great value. The invesfigators have demonstrated, with published and preliminary data, that two approaches can suppress signaling in the osteogenic pathway and reduce calcification of the aortic valve. Pharmacological interventions and complementary genetically altered mice will be used to examine mechanisms that may contribute to CAVS. The investigators will measure gene expression in aortic valves of mice, and function of the valve. One goal is to detennine whether osteoprotegerin (OPG), an endogenous decoy receptor of receptor- activator of NFKB ligand (RANKL), decreases expression of osteogenic genes, reduces calcification of the valve, and slows progression of aortic stenosis in mice with moderate aortic stenosis. Studies also are proposed to test the hypothesis that OPG deficiency (OPG"'' mice) accelerates CAVS. The second goal is to determine whether two interacting endogenous systems, renin-angiotensin and PPARy, modulate development of CAVS. One hypothesis is that ATI receptors contribute to development of CAVS. Studies are planned to determine whether an antagonist of ATI receptors (but not an angiotensin- converting enzyme inhibitor) decreases expression of osteogenic genes and inhibits development of CAVS in Reversa mice. Studies also are planned to test the hypothesis that susceptibility to CAVS is reduced in ATlr"'' mice. Finally, studies are planned to test the hypotheses that pioglitazone (a PPARy ligand) protects against development of CAVS in Reversa mice and, in endothelium-targeted dominant negative PPARy mice (E-V290M), susceptibility to CAVS is increased. The goal of this project is to use an experimental model of CAVS with hemodynamically significant stenosis to clarify molecular mechanisms of CAVS, functional consequences of calcification, and to explore possible therapeutic approaches. RELEVANCE (See instructions): Calcific aortic valve stenosis (CAVS) is a common clinical problem, and is the second most common indication for cardiac surgery. These studies will determine whether three novel therapeutic interventions may slow, or reverse, the progression of CAVS. If any one of these approaches proves to be effective in slowing progression of CAVS, it could lead to clinical studies that fundamentally alter clinical treatment of CAVS.

目前资助期内的研究主要集中在氧化应激对心血管的影响上。